Immediate Impact

3 by Nobel laureates 28 from Science/Nature 86 standout
Sub-graph 1 of 20

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
4 intermediate papers

Works of Susan Quinn being referenced

A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors
2009
Phase I Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors
2006
and 1 more

Author Peers

Author Last Decade Papers Cites
Susan Quinn 595 677 404 14 890
Guenther R. Adolf 464 664 472 15 1.0k
Oliver Kraemer 448 477 436 9 893
Martina Uttenreuther‐Fischer 657 880 348 32 1.1k
Bianco Ar 428 607 325 7 831
Damiano 433 604 327 5 837
Griswold Dp 187 492 340 19 878
Uri Sagman 230 460 378 19 900
David Taber 463 635 439 28 1.1k
Douglas Bootle 301 572 705 17 1.1k
Axel R. Hanauske 480 418 421 19 1.0k

All Works

Loading papers...

Rankless by CCL
2026